SK285682B6 - 2-(1H-Indol-3-yl)-2-oxo-acetamidy, farmaceutický prostriedok s ich obsahom a ich použitie - Google Patents

2-(1H-Indol-3-yl)-2-oxo-acetamidy, farmaceutický prostriedok s ich obsahom a ich použitie Download PDF

Info

Publication number
SK285682B6
SK285682B6 SK896-2002A SK8962002A SK285682B6 SK 285682 B6 SK285682 B6 SK 285682B6 SK 8962002 A SK8962002 A SK 8962002A SK 285682 B6 SK285682 B6 SK 285682B6
Authority
SK
Slovakia
Prior art keywords
oxo
indol
chlorobenzyl
dihydrofuran
acetamide
Prior art date
Application number
SK896-2002A
Other languages
English (en)
Slovak (sk)
Other versions
SK8962002A3 (en
Inventor
Ernesto Menta
Nicoletta Pescalli
Original Assignee
Novuspharma S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novuspharma S.P.A. filed Critical Novuspharma S.P.A.
Publication of SK8962002A3 publication Critical patent/SK8962002A3/sk
Publication of SK285682B6 publication Critical patent/SK285682B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SK896-2002A 1999-12-23 2000-12-21 2-(1H-Indol-3-yl)-2-oxo-acetamidy, farmaceutický prostriedok s ich obsahom a ich použitie SK285682B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI002693A IT1315267B1 (it) 1999-12-23 1999-12-23 Derivati di 2-(1h-indol-3-il)-2-oxo-acetammidi ad attivita'antitumorale
PCT/EP2000/013068 WO2001047916A1 (en) 1999-12-23 2000-12-21 2-(1h-indol-3-yl)-2-oxo-acetamides with antitumor activity

Publications (2)

Publication Number Publication Date
SK8962002A3 SK8962002A3 (en) 2002-11-06
SK285682B6 true SK285682B6 (sk) 2007-06-07

Family

ID=11384182

Family Applications (1)

Application Number Title Priority Date Filing Date
SK896-2002A SK285682B6 (sk) 1999-12-23 2000-12-21 2-(1H-Indol-3-yl)-2-oxo-acetamidy, farmaceutický prostriedok s ich obsahom a ich použitie

Country Status (24)

Country Link
US (1) US6753342B2 (ru)
EP (1) EP1244652B1 (ru)
JP (1) JP2003519140A (ru)
KR (1) KR100795533B1 (ru)
CN (1) CN1250542C (ru)
AT (1) ATE302772T1 (ru)
AU (1) AU776332B2 (ru)
BR (1) BR0016553A (ru)
CA (1) CA2395205A1 (ru)
CZ (1) CZ20022170A3 (ru)
DE (1) DE60022227T2 (ru)
EA (1) EA004925B1 (ru)
ES (1) ES2246918T3 (ru)
HU (1) HUP0203524A3 (ru)
IL (2) IL150329A0 (ru)
IT (1) IT1315267B1 (ru)
MX (1) MXPA02006217A (ru)
NO (1) NO323312B1 (ru)
NZ (1) NZ519689A (ru)
PL (1) PL356541A1 (ru)
SK (1) SK285682B6 (ru)
TR (1) TR200201613T2 (ru)
WO (1) WO2001047916A1 (ru)
ZA (1) ZA200204964B (ru)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE330955T1 (de) 1998-04-28 2006-07-15 Elbion Ag Indolderivate und deren verwendung als inhibitoren der phosphodiesterase 4.
IT1318641B1 (it) * 2000-07-25 2003-08-27 Novuspharma Spa Ammidi di acidi 2-(1h-indol-3-il)-2-oxo-acetici ad attivita'antitumorale.
DE10037310A1 (de) * 2000-07-28 2002-02-07 Asta Medica Ag Neue Indolderivate und deren Verwendung als Arzneimittel
AU2003265267B2 (en) * 2002-07-09 2010-03-11 Fasgen, Llc Novel compounds, pharmaceutical compositions containing same, and methods of use for same
CN102060806A (zh) 2003-09-11 2011-05-18 iTherX药品公司 细胞因子抑制剂
ES2345662T3 (es) * 2004-03-11 2010-09-29 Actelion Pharmaceuticals Ltd. Derivados de acido indol-1-il-acetico.
US7645789B2 (en) 2006-04-07 2010-01-12 Vertex Pharmaceuticals Incorporated Indole derivatives as CFTR modulators
RU2451018C2 (ru) 2006-04-07 2012-05-20 Вертекс Фармасьютикалз Инкорпорейтед Модуляторы атф-связывающих кассетных транспортеров
US10022352B2 (en) 2006-04-07 2018-07-17 Vertex Pharmaceuticals Incorporated Modulators of ATP-binding cassette transporters
JP5406716B2 (ja) * 2006-08-07 2014-02-05 アイアンウッド ファーマシューティカルズ インコーポレイテッド インドール化合物
US8563573B2 (en) 2007-11-02 2013-10-22 Vertex Pharmaceuticals Incorporated Azaindole derivatives as CFTR modulators
US8802868B2 (en) 2010-03-25 2014-08-12 Vertex Pharmaceuticals Incorporated Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide
EP3045452A1 (en) 2010-04-22 2016-07-20 Vertex Pharmaceuticals Inc. Process of producing cycloalkylcarboxamido-indole compounds
AR084433A1 (es) 2010-12-22 2013-05-15 Ironwood Pharmaceuticals Inc Inhibidores de la faah y composiciones farmaceuticas que los contienen
US9056851B2 (en) 2011-03-25 2015-06-16 The Research Foundation For The State University Of New York Thiolactone antibiotics
AR092857A1 (es) 2012-07-16 2015-05-06 Vertex Pharma Composiciones farmaceuticas de (r)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-il)-n-(1-(2,3-dihidroxipropil)-6-fluoro-2-(1-hidroxi-2-metilpropan-2-il)-1h-indol-5-il)ciclopropancarboxamida y administracion de las mismas
HRP20230709T1 (hr) 2014-04-15 2023-10-13 Vertex Pharmaceuticals Incorporated Farmaceutski pripravci za liječenje bolesti povezanih s regulatorom provodljivosti transmembrane cistične fibroze
CN115785079B (zh) * 2022-11-28 2024-02-13 沈阳药科大学 4-(1h-吲哚-5-基)氨基呋喃-2(5h)-酮类化合物及其制备和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK13598A3 (en) * 1995-08-02 1998-06-03 Univ Newcastle Ventures Ltd Benzimidazole compounds
CO4970714A1 (es) * 1997-09-05 2000-11-07 Boehringer Mannheim Gmbh Derivados ureido y tioureido de 4-amino-2(5h)-furanonas y 4-amino-2(5h) tiofenonas como agentes antitumorales
DE19814838C2 (de) * 1998-04-02 2001-01-18 Asta Medica Ag Indolyl-3-glyoxylsäure-Derivate mit Antitumorwirkung
ATE330955T1 (de) * 1998-04-28 2006-07-15 Elbion Ag Indolderivate und deren verwendung als inhibitoren der phosphodiesterase 4.

Also Published As

Publication number Publication date
AU2170401A (en) 2001-07-09
CZ20022170A3 (cs) 2002-09-11
ES2246918T3 (es) 2006-03-01
EP1244652A1 (en) 2002-10-02
WO2001047916A1 (en) 2001-07-05
KR100795533B1 (ko) 2008-01-16
MXPA02006217A (es) 2004-02-26
CN1250542C (zh) 2006-04-12
DE60022227T2 (de) 2006-06-22
US20030158153A1 (en) 2003-08-21
AU776332B2 (en) 2004-09-02
NZ519689A (en) 2004-02-27
ATE302772T1 (de) 2005-09-15
SK8962002A3 (en) 2002-11-06
JP2003519140A (ja) 2003-06-17
NO323312B1 (no) 2007-03-12
CN1413205A (zh) 2003-04-23
HUP0203524A2 (hu) 2003-03-28
BR0016553A (pt) 2002-09-17
EA200200558A1 (ru) 2002-12-26
IL150329A0 (en) 2002-12-01
ZA200204964B (en) 2004-01-29
ITMI992693A1 (it) 2001-06-23
ITMI992693A0 (it) 1999-12-23
EA004925B1 (ru) 2004-10-28
PL356541A1 (en) 2004-06-28
CA2395205A1 (en) 2001-07-05
US6753342B2 (en) 2004-06-22
DE60022227D1 (de) 2005-09-29
HUP0203524A3 (en) 2008-01-28
NO20022976D0 (no) 2002-06-20
NO20022976L (no) 2002-06-20
EP1244652B1 (en) 2005-08-24
IL150329A (en) 2006-07-05
IT1315267B1 (it) 2003-02-03
KR20020063247A (ko) 2002-08-01
TR200201613T2 (tr) 2002-10-21

Similar Documents

Publication Publication Date Title
SK285682B6 (sk) 2-(1H-Indol-3-yl)-2-oxo-acetamidy, farmaceutický prostriedok s ich obsahom a ich použitie
EP1511742B1 (en) Kinase inhibitors
EP2829539B1 (fr) Nouveaux derives de pyrrole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CA2509982C (en) N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them
KR100191973B1 (ko) 5-아릴인돌 유도체
AU732863B2 (en) Indole derivatives having combined 5HT1A, 5HT1B and 5HT1D receptor antagonist activity
SK5462003A3 (en) Indolylmaleimide derivatives, method for the preparation thereof and pharmaceutical composition comprising same
TW386991B (en) Indoloylguanidine derivatives
KR20070043900A (ko) 인돌릴말레이미드 유도체
JP2002535331A (ja) 新規血管形成阻害薬
EP1689739B1 (en) Azole-based kinase inhibitors
CA2917965C (fr) Nouveaux derives d'indole et de pyrrole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
AU2006268908A1 (en) Indolylmaleimide derivatives
KR20090100363A (ko) 키나제 억제제로서의 인돌릴말레이미드 유도체
AU2013249714A1 (en) Indolin-2-one derivatives as protein kinase inhibitors
JP2004504398A (ja) 抗腫瘍活性を有する２−（１ｈ−インドール−３−イル）−２−オキソ−酢酸アミド
JPH0832703B2 (ja) ベンゾイミダゾールの新規誘導体、それらの製法、及びそれらの医薬用途
WO2024180103A1 (en) Sting agonists containing benzylic alcohol and benzylic amine functional groups

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20091221